Biomedical sciences

Approaches to therapy that have long been stuck in the lab are finally finding their way into the clinic.

After years of setbacks, the field is starting to deliver on its promises.

The field’s overall footprint in the Nature Index continues to grow, but trends vary at regional and institutional levels.

Solving the public health crisis will take time, money and cooperation.

With a dearth of new antibiotics coming to market, researchers are finding creative ways to keep bacteria at bay.

Miniaturized versions of human tissue offer greater complexity than the Petri dish and could be an alternative to animal testing.

The US Food and Drug Administration is looking at ways to lower approved doses to improve quality of life during chemotherapy.

A description of the terminology and methodology used in this supplement, and a guide to the functionality that is available free online at natureindex.com.

New technologies to overcome gene-therapy bottlenecks and use organoids clinically could result in fresh treatments for debilitating neurodegenerative and digestive diseases.

A conversation with Athanasios Typas, group leader in the Genome Biology Unit at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, and winner of the 2022 Liliane Bettencourt Prize for Life Sciences from Fondation Bettencourt Schueller

An enzyme that modifies tumour surface glycans so that cells can break free and travel to other parts of the body is identified as crucial for ovarian cancer metastasis.

Bioimaging insights are helping researchers at the Rudolf Virchow Center to improve the understanding and treatment of disease.

Leading surgical, bioprinting and imaging facilities at the Center for Biomedical Research in Vienna aim to bring new possibilities in cardiovascular medicine.